Lyell Immunopharma (LYEL) Research & Development (2020 - 2025)
Historic Research & Development for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to $28.2 million.
- Lyell Immunopharma's Research & Development fell 2867.85% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.1 million, marking a year-over-year decrease of 870.12%. This contributed to the annual value of $171.6 million for FY2024, which is 619.97% down from last year.
- Lyell Immunopharma's Research & Development amounted to $28.2 million in Q3 2025, which was down 2867.85% from $34.9 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Research & Development registered a high of $48.7 million during Q4 2024, and its lowest value of $19.3 million during Q4 2021.
- Moreover, its 5-year median value for Research & Development was $41.6 million (2022), whereas its average is $39.9 million.
- As far as peak fluctuations go, Lyell Immunopharma's Research & Development plummeted by 5219.24% in 2021, and later surged by 9721.03% in 2022.
- Lyell Immunopharma's Research & Development (Quarter) stood at $19.3 million in 2021, then surged by 97.21% to $38.0 million in 2022, then grew by 23.57% to $47.0 million in 2023, then grew by 3.56% to $48.7 million in 2024, then plummeted by 42.11% to $28.2 million in 2025.
- Its last three reported values are $28.2 million in Q3 2025, $34.9 million for Q2 2025, and $43.4 million during Q1 2025.